BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 583866)

  • 1. Fosfomycin: Laboratory studies.
    Woodruff HB; Mata JM; Hernández S; Mochales S; Rodríguez A; Stapley EO; Wallick H; Miller AK; Hendlin D
    Chemotherapy; 1977; 23 Suppl 1():1-22. PubMed ID: 583866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New perspectives for reassessing fosfomycin: applicability in current clinical practice.
    Candel FJ; Matesanz David M; Barberán J
    Rev Esp Quimioter; 2019 May; 32 Suppl 1(Suppl 1):1-7. PubMed ID: 31131586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New microbiological aspects of fosfomycin.
    Díez-Aguilar M; Cantón R
    Rev Esp Quimioter; 2019 May; 32 Suppl 1(Suppl 1):8-18. PubMed ID: 31131587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The revival of fosfomycin.
    Michalopoulos AS; Livaditis IG; Gougoutas V
    Int J Infect Dis; 2011 Nov; 15(11):e732-9. PubMed ID: 21945848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parenteral Fosfomycin for the Treatment of Multidrug Resistant Bacterial Infections: The Rise of the Epoxide.
    Trinh TD; Smith JR; Rybak MJ
    Pharmacotherapy; 2019 Nov; 39(11):1077-1094. PubMed ID: 31487056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro sensitivity of anaerobic bacteria to fosfomycin.
    Altés Gutiérrez A; Rodríguez Noriega A
    Chemotherapy; 1977; 23 Suppl 1():51-7. PubMed ID: 583867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous fosfomycin for the treatment of hospitalized patients with serious infections.
    Shorr AF; Pogue JM; Mohr JF
    Expert Rev Anti Infect Ther; 2017 Oct; 15(10):935-945. PubMed ID: 28901793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-kill evaluation of antimicrobial regimens against clinical isolates of penicillin-resistant Streptococcus pneumoniae.
    Bañón Arias R; García López M; Pinedo Sánchez A
    J Chemother; 2001 Oct; 13(5):535-40. PubMed ID: 11760218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fosfomycin: Resurgence of an old companion.
    Sastry S; Doi Y
    J Infect Chemother; 2016 May; 22(5):273-80. PubMed ID: 26923259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-wall-inhibiting antibiotic combinations with activity against multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
    Hickman RA; Hughes D; Cars T; Malmberg C; Cars O
    Clin Microbiol Infect; 2014 Apr; 20(4):O267-73. PubMed ID: 24118201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Microbiological and pharmacokinetic aspects of antibiotic therapy].
    Pomarelli P
    Farmaco Prat; 1975 Jun; 30(6):257-81. PubMed ID: 1040575
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fosfomycin: past, present and future].
    Baylan O
    Mikrobiyol Bul; 2010 Apr; 44(2):311-21. PubMed ID: 20549968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of action of fosfomycin (phosphonomycin).
    Kahan FM; Kahan JS; Cassidy PJ; Kropp H
    Ann N Y Acad Sci; 1974 May; 235(0):364-86. PubMed ID: 4605290
    [No Abstract]   [Full Text] [Related]  

  • 14. Fosfomycin in the treatment of bacterial infections: summary of clinical trials in Japan.
    Fujii R
    Chemotherapy; 1977; 23 Suppl 1():234-46. PubMed ID: 832522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reevaluation of fosfomycin: clinical and laboratory studies.
    Dai ZY; Zhang YY; Zhang MF; Zhang ZL; Zhang JD; Liu YK
    Chin Med J (Engl); 1981 Oct; 94(10):645-52. PubMed ID: 6797798
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fosfomycin, a new antibiotic: in vitro activity compared with mezlocillin, cefuroxime and gentamicin].
    Lindenschmidt EG; Schassan HH
    Immun Infekt; 1980; 8(4):121-6. PubMed ID: 6453080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fosfomycin].
    Gobernado M
    Rev Esp Quimioter; 2003 Mar; 16(1):15-40. PubMed ID: 12750755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fosfomycin, antimicrobial activity in vitro and in vivo.
    Goto S
    Chemotherapy; 1977; 23 Suppl 1():63-74. PubMed ID: 401721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of the antibacterial activity of water and ether extracts of fosfomycin and azidocillin].
    Pase U; Fusetti F; Nicolin T
    G Stomatol Ortognatodonzia; 1983; 2(2):57-9. PubMed ID: 6441786
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of combination of benzylpenicillin and fosfomycin on penicillin-resistant Streptococcus pneumoniae.
    Kikuchi K; Totsuka K; Shimizu K; Ishii T; Yoshida T; Orikasa Y
    Microb Drug Resist; 1995; 1(2):185-9. PubMed ID: 9158754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.